Stories for Annette Berthod

@annetteberthod · Become a member

HCC treatment algorithm with systemic therapy based on the recently updated HCC guidelines

Professor He and Professor Pinter, discuss their perspectives and experience on how to select systemic therapy options in first line and beyond for patients with advanced or unresectable HCC based on the current international HCC guidelines.

Assoc. Prof. Aiwu Ruth He Assoc. Prof. Matthias Pinter

EXPERT VIEW   |   30 MIN   |   NOV 2021

PARP inhibitors in prostate cancer and the latest developments

Prof. Neeraj Agarwal takes a look at poly-ADP ribose polymerase inhibitors (PARPi's) in prostate cancer and in particular the latest clinical developments.

Prof. Neeraj Agarwal

EXPERT VIEW   |   5 MIN   |   MAR 2022

TRK fusion-positive cancer: new ESMO OncologyPRO learning resource

NTRK CONNECT has developed a comprehensive resource, available at ESMO OncologyPRO, providing information on TRK fusion proteins as a therapeutic target for specific patients across multiple tumour types.

Prof. Ezra Cohen Prof. Silvia Stacchiotti Prof. Silvia Stacchiotti

See more experts

ONCOLOGYPRO   |   30 MIN   |   SEP 2022

Optimising treatment sequencing for mCRC, third line and beyond

How can oncology practitioners optimise treatment sequencing for patients with metastatic colorectal cancer (mCRC), third line and beyond?

Prof. Sebastian Stintzing Dr. Juan Manuel O'Connor

EXPERT VIEW   |   9 MIN   |   JAN 2023